Similarly, after BCG treatment, PD-L1 expression levels were increased on inflammatory cells in non-tumor normal tissues from 15 (83%) of 18 patients, but were decreased in 2 (11%) patients (Table 2). This evidence concerns the gene CD274 and neoplasm.